TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 101 filers reported holding TANGO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,415,631 | +297.7% | 5,276,699 | +17.3% | 1.33% | +309.6% |
| Q2 2023 | $14,940,000 | -15.9% | 4,500,000 | 0.0% | 0.32% | -19.6% |
| Q1 2023 | $17,775,000 | -45.5% | 4,500,000 | 0.0% | 0.40% | -52.1% |
| Q4 2022 | $32,625,000 | +100.3% | 4,500,000 | 0.0% | 0.84% | +91.8% |
| Q3 2022 | $16,290,000 | -20.1% | 4,500,000 | 0.0% | 0.44% | -24.0% |
| Q2 2022 | $20,385,000 | -29.3% | 4,500,000 | +18.2% | 0.58% | +3.2% |
| Q1 2022 | $28,849,000 | -12.1% | 3,805,929 | +26.9% | 0.56% | -11.1% |
| Q4 2021 | $32,820,000 | -15.4% | 3,000,000 | 0.0% | 0.63% | -23.9% |
| Q3 2021 | $38,790,000 | – | 3,000,000 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $218,038,359 | 82.15% |
| Nextech Invest Ltd. | 5,533,980 | $62,312,615 | 18.88% |
| Boxer Capital, LLC | 7,123,642 | $80,212,209 | 4.27% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $32,571,385 | 3.64% |
| EcoR1 Capital, LLC | 8,721,636 | $98,205,621 | 3.31% |
| Samsara BioCapital, LLC | 630,000 | $7,093,800 | 2.17% |
| Soleus Capital Management, L.P. | 1,929,019 | $21,720,754 | 2.00% |
| Casdin Capital, LLC | 1,307,349 | $14,720,750 | 1.63% |
| Southpoint Capital Advisors LP | 5,276,699 | $59,415,631 | 1.33% |
| Affinity Asset Advisors, LLC | 350,000 | $3,941,000 | 1.11% |